Karyopharm Therapeutics
KPTI
#8602
Rank
NZ$0.16 B
Marketcap
$1.34
Share price
14.66%
Change (1 day)
-34.08%
Change (1 year)

Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2013

Volume in USD (price x number of shares), data since 2013

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$1.46 M-97.33%
2023NZ$54.81 M18.97%
2022NZ$46.07 M5.78%
2021NZ$43.55 M77.73%
2020NZ$24.5 M33.34%
2019NZ$18.38 M106.04%
2018NZ$8.92 M-65.24%
2017NZ$25.66 M334.29%
2016NZ$5.9 M-84.55%
2015NZ$38.24 M-42.24%
2014NZ$66.21 M11206.31%
2013NZ$0.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
NZ$34.8 MNZ$96.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.92 MNZ$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.74 MNZ$0.13 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.68 MNZ$11.53 M๐Ÿ‡บ๐Ÿ‡ธ USA